Skip to main content
Journal cover image

Multiplex protein screening of biomarkers associated with major bleeding in patients with atrial fibrillation treated with oral anticoagulation.

Publication ,  Journal Article
Siegbahn, A; Lindbäck, J; Hijazi, Z; Åberg, M; Alexander, JH; Eikelboom, JW; Lopes, RD; Pol, T; Oldgren, J; Granger, CB; Yusuf, S; Wallentin, L
Published in: J Thromb Haemost
November 2021

BACKGROUND: Oral anticoagulants (OAC) in patients with atrial fibrillation (AF) prevent thromboembolic events, but are associated with significant risk of bleeding. OBJECTIVES: To explore associations between a wide range of biomarkers and bleeding risk in patients with AF on OAC. METHOD: Biomarkers were analyzed in a random sample of 4200 patients, 204 cases with major bleedings, from ARISTOTLE. The replication cohort included 344 cases with major bleeding and 1024 random controls from RE-LY. Plasma samples obtained at randomization were analyzed by the Olink Proximity Extension Assay cardiovascular and inflammation panels and conventional immunoassays. The associations between biomarker levels and major bleeding over 1 to 3 years of follow-up were evaluated by random survival forest/Boruta analyses and Cox regression analyses to assess linear associations and hazard ratios for identified biomarkers. RESULTS: Out of 268 proteins, nine biomarkers were independently associated with bleeding in both cohorts. In the replication cohort the linear hazard ratios (95% confidence intervals) per interquartile range were for these biomarkers: TNF-R1 1.748 (1.456, 2.098), GDF-15 1.653 (1.377, 1.985), EphB4 1.575 (1.320, 1.880), suPAR 1.548 (1.294, 1.851), OPN 1.476 (1.240, 1.757), OPG 1.397 (1.156, 1.688), TNF-R2 1.360 (1.144,1.616), cTnT-hs 1.232 (1.067, 1.423), and TRAIL-R2 1.202 (1.069, 1.351). CONCLUSIONS: In patients with AF on OAC, GDF-15, cTnT-hs, and seven novel biomarkers were independently associated with major bleedings and reflect pathophysiologic processes of inflammation, apoptosis, oxidative stress, vascular calcification, coagulation, and fibrinolysis. Investigations of the utility of these markers to refine risk stratification and guide the management of patients at high risk of bleeding are warranted.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Thromb Haemost

DOI

EISSN

1538-7836

Publication Date

November 2021

Volume

19

Issue

11

Start / End Page

2726 / 2737

Location

England

Related Subject Headings

  • Thromboembolism
  • Stroke
  • Risk Factors
  • Humans
  • Hemorrhage
  • Cardiovascular System & Hematology
  • Biomarkers
  • Atrial Fibrillation
  • Anticoagulants
  • Administration, Oral
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Siegbahn, A., Lindbäck, J., Hijazi, Z., Åberg, M., Alexander, J. H., Eikelboom, J. W., … Wallentin, L. (2021). Multiplex protein screening of biomarkers associated with major bleeding in patients with atrial fibrillation treated with oral anticoagulation. J Thromb Haemost, 19(11), 2726–2737. https://doi.org/10.1111/jth.15498
Siegbahn, Agneta, Johan Lindbäck, Ziad Hijazi, Mikael Åberg, John H. Alexander, John W. Eikelboom, Renato D. Lopes, et al. “Multiplex protein screening of biomarkers associated with major bleeding in patients with atrial fibrillation treated with oral anticoagulation.J Thromb Haemost 19, no. 11 (November 2021): 2726–37. https://doi.org/10.1111/jth.15498.
Siegbahn A, Lindbäck J, Hijazi Z, Åberg M, Alexander JH, Eikelboom JW, et al. Multiplex protein screening of biomarkers associated with major bleeding in patients with atrial fibrillation treated with oral anticoagulation. J Thromb Haemost. 2021 Nov;19(11):2726–37.
Siegbahn, Agneta, et al. “Multiplex protein screening of biomarkers associated with major bleeding in patients with atrial fibrillation treated with oral anticoagulation.J Thromb Haemost, vol. 19, no. 11, Nov. 2021, pp. 2726–37. Pubmed, doi:10.1111/jth.15498.
Siegbahn A, Lindbäck J, Hijazi Z, Åberg M, Alexander JH, Eikelboom JW, Lopes RD, Pol T, Oldgren J, Granger CB, Yusuf S, Wallentin L. Multiplex protein screening of biomarkers associated with major bleeding in patients with atrial fibrillation treated with oral anticoagulation. J Thromb Haemost. 2021 Nov;19(11):2726–2737.
Journal cover image

Published In

J Thromb Haemost

DOI

EISSN

1538-7836

Publication Date

November 2021

Volume

19

Issue

11

Start / End Page

2726 / 2737

Location

England

Related Subject Headings

  • Thromboembolism
  • Stroke
  • Risk Factors
  • Humans
  • Hemorrhage
  • Cardiovascular System & Hematology
  • Biomarkers
  • Atrial Fibrillation
  • Anticoagulants
  • Administration, Oral